ATRS

Antares Pharma, Inc.

Delisted

ATRS was delisted on the 23rd of May, 2022.

101 hedge funds and large institutions have $157M invested in Antares Pharma, Inc. in 2018 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 30 increasing their positions, 24 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
101
Holders Change
-1
Holders Change %
-0.98%
% of All Funds
2.32%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
14
Increased
30
Reduced
24
Closed
15
Calls
$560K
Puts
$266K
Net Calls
+$294K
Net Calls Change
+$289K
Name Holding Trade Value Shares
Change
Shares
Change %
GC
101
Guggenheim Capital
Illinois
-$1.17M -530,246 Closed
GPP
102
Great Point Partners
Connecticut
-$1.1M -500,000 Closed
TF
103
TIAA FSB
Florida
-$1.08M -491,000 Closed
GCP
104
GSA Capital Partners
United Kingdom
-$513K -233,300 Closed
DZ Bank
105
DZ Bank
Germany
-$477K -216,709 Closed
Two Sigma Advisers
106
Two Sigma Advisers
New York
-$47K -21,332 Closed
SRAM
107
Stone Ridge Asset Management
New York
-$39K -17,740 Closed
ECM
108
Element Capital Management
New York
-$32K -14,453 Closed
BCM
109
BlueCrest Capital Management
Jersey
-$31K -14,019 Closed
CSS
110
Cubist Systematic Strategies
Connecticut
-$30K -13,513 Closed
SG Americas Securities
111
SG Americas Securities
New York
-$27K -12,052 Closed
Simplex Trading
112
Simplex Trading
Illinois
-$16K -7,614 Closed
KF
113
Krilogy Financial
Missouri
-$6K -2,500 Closed
TRCT
114
Tower Research Capital (TRC)
New York
-$2K -832 Closed